The global Mesenchymal Stem Cells (MSCs) Market, valued at US$ 3.2 billion in 2022, is projected to grow at a robust compound annual growth rate (CAGR) of 12.7% from 2023 to 2031, surpassing US$ 10.1 billion by 2031. MSCs, multipotent stem cells derived from bone marrow, adipose tissue, and umbilical cord, are used in regenerative medicine for conditions like osteoarthritis, cardiovascular...

"Executive Summary Placental Stem Cells (PSCS) Market :  Data Bridge Market Research analyses that the placental stem cells (PSCS) market which is USD 1 billion in 2022, is expected to reach USD 4.91 billion by 2030, at a CAGR of 22% during the forecast period 2023 to 2030.   Placental Stem Cells (PSCS) Market report has CAGR value fluctuations during the forecast...

The global Stem Cells Market, valued at US$ 92.5 billion in 2024, is projected to grow at a compound annual growth rate (CAGR) of 10.5% from 2025 to 2035, surpassing US$ 280.2 billion by 2035. Stem cells, including embryonic, adult, and induced pluripotent stem cells (iPSCs), are pivotal in regenerative medicine, treating conditions like cancer, neurological disorders, and cardiovascular...